FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36053011000001101: Granisetron 3.1mg/24hours transdermal patches (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111081201000001113 Granisetron 3.1mg/24hours transdermal patches (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111081301000001116 Granisetron 3.1mg/24hours transdermal patches en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Granisetron 3.1mg/24hours transdermal patches Is a Granisetron true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route patch.transdermal ontology form and route true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Transdermal route true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Plays role Antiemetic therapeutic role true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Is a Product containing granisetron false Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Has active ingredient Granisetron false Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Has specific active ingredient Granisetron true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Granisetron 3.1mg/24hours transdermal patches (Imported) Is a True Granisetron 3.1mg/24hours transdermal patches Inferred relationship Existential restriction modifier
Granisetron 3.1mg/24hours transdermal patches 1 patch Has VMP True Granisetron 3.1mg/24hours transdermal patches Inferred relationship Existential restriction modifier
Sancuso 3.1mg/24hours transdermal patches (ProStrakan Ltd) Is a True Granisetron 3.1mg/24hours transdermal patches Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start